Novavax, Inc. Soared

Tue, Jan 21, 2020 at 05:30 PM

Novavax, Inc. (NVAX:NASDAQ) soared at $9.82, a gain of 71.1%. The stock got featured on our News Catalysts scanner on Thu 16 Jan 20 at 12:02 PM in the 'BIOTECH' category. From Fri 27 Dec 19, the stock recorded 57.14% Up Days and 40.00% Green Days

About Novavax, Inc. (NVAX:NASDAQ)

Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

Top 10 Gainers:

Genprex, Inc. (GNPX:NASDAQ), 219.44%
NanoViricides, Inc. (NNVC:NYSEMKT), 152.98%
CSS Industries, Inc. (CSS:NYSE), 100%
Novavax, Inc. (NVAX:NASDAQ), 71.08%
BioPharmX Corporation (BPMX:NYSEMKT), 59.57%
AIM ImmunoTech Inc. (AIM:NYSEMKT), 47.95%
China Pharma Holdings, Inc. (CPHI:NYSEMKT), 39.88%
Alpha Pro Tech, Ltd. (APT:NYSEMKT), 38.57%
iBio, Inc. (IBIO:NYSEMKT), 36.23%
Vaxart, Inc. (VXRT:NASDAQ), 35.9%